EGA-IfWH Lunchtime Seminar Series

Dr. Bitler received his Ph.D. in Cancer Biology from the University of Arizona Cancer Center. As a graduate student his main interest was in the development of novel anti-breast cancer peptide-based therapies. He continued his post-doctoral training at Fox Chase Cancer Center and The Wistar Institute in Philadelphia, PA. During this time, he shifted his research focus to ovarian cancer, Wnt signaling, and epigenetics. Dr. Bitler is committed to the fight against cancer through his work to elucidate the impact of cancer-related signaling and epigenetic regulation.